Long‐term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy.

Published in:

Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 1, p. 65, doi. 10.1111/apt.14794

By:

• Sandborn, W. J.;
• Rutgeerts, P.;
• Gasink, C.;
• Jacobstein, D.;
• Zou, B.;
• Johanns, J.;
• Sands, B. E.;
• Hanauer, S. B.;
• Targan, S.;
• Ghosh, S.;
• de Villiers, W. J. S.;
• Colombel, J.‐F.;
• Feagan, B. G.

Publication type:

Article